CD180

CD180 antigen is a protein that in humans is encoded by the CD180 gene.[4][5][6][7]

CD180
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesCD180, LY64, Ly78, RP105, CD180 molecule
External IDsOMIM: 602226 MGI: 1194924 HomoloGene: 4077 GeneCards: CD180
Gene location (Human)
Chr.Chromosome 5 (human)[1]
Band5q12.3Start67,179,613 bp[1]
End67,196,799 bp[1]
RNA expression pattern
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez

4064

17079

Ensembl

ENSG00000134061

ENSMUSG00000021624

UniProt

Q99467

Q62192

RefSeq (mRNA)

NM_005582

NM_008533
NM_001360519

RefSeq (protein)

NP_005573

NP_032559
NP_001347448

Location (UCSC)Chr 5: 67.18 – 67.2 Mbn/a
PubMed search[2][3]
Wikidata
View/Edit HumanView/Edit Mouse

CD180 is a cell surface molecule consisting of extracellular leucine-rich repeats (LRR) and a short cytoplasmic tail. It is also known by the archaic terms Bgp-95 and RP105, for the founding designations following discovery in humans (1988) and mice (1994), respectively. CD180 is expressed on antigen presenting cells including B cells and dendritic cells. The extracellular LRR is associated with a molecule called MD-1 and form the cell surface receptor complex, CD180/MD-1. It belongs to the family of pathogen receptors, Toll-like receptors (TLR). CD180/MD-1, by working in concert with TLR4, controls B cell recognition and signaling of lipopolysaccharide (LPS), a membrane constituent of Gram-negative bacteria.[6]

Recently, CD180 has been demonstrated to be involved in the survival and prognosis of B-cell chronic lymphocytic leukemia.[8][9]

References

  1. GRCh38: Ensembl release 89: ENSG00000134061 - Ensembl, May 2017
  2. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  3. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. Miura Y, Shimazu R, Miyake K, Akashi S, Ogata H, Yamashita Y, Narisawa Y, Kimoto M (Nov 1998). "RP105 is associated with MD-1 and transmits an activation signal in human B cells". Blood. 92 (8): 2815–22. doi:10.1182/blood.V92.8.2815. PMID 9763566.
  5. Miura Y, Miyake K, Yamashita Y, Shimazu R, Copeland NG, Gilbert DJ, Jenkins NA, Inazawa J, Abe T, Kimoto M (Mar 1997). "Molecular cloning of a human RP105 homologue and chromosomal localization of the mouse and human RP105 genes (Ly64 and LY64)". Genomics. 38 (3): 299–304. doi:10.1006/geno.1996.0632. PMID 8975706.
  6. "Entrez Gene: CD180 CD180 molecule".
  7. [4]
  8. Porakishvili, Nino; Memon, Azka; Vispute, Ketki; Kulikova, Nina; Clark, Edward A.; Rai, Kanti R.; Nathwani, Amit; Damle, Rajendra N.; Chiorazzi, Nicholas; Lydyard, Peter M. (May 2011). "CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells". British Journal of Haematology. 153 (4): 486–498. doi:10.1111/j.1365-2141.2011.08605.x. ISSN 0007-1048. PMID 21443749. S2CID 13360804.
  9. Gordiienko, Inna; Shlapatska, Larysa; Kholodniuk, Valeriia; Sklyarenko, Lilia; Gluzman, Daniel F.; Clark, Edward A.; Sidorenko, Svetlana P. (2017-10-05). "The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling". PLOS ONE. 12 (10): e0185940. Bibcode:2017PLoSO..1285940G. doi:10.1371/journal.pone.0185940. ISSN 1932-6203. PMC 5628907. PMID 28982149.

Further reading

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.